Axon Enterprise, Inc. (NASDAQ:AXON) Shares Sold by Beese Fulmer Investment Management Inc.

Beese Fulmer Investment Management Inc. cut its holdings in Axon Enterprise, Inc. (NASDAQ:AXON) by 1.8% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 4,068 shares of the biotechnology company’s stock after selling 73 shares during the quarter. Beese Fulmer Investment Management Inc.’s holdings in Axon Enterprise were worth $2,418,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also made changes to their positions in AXON. Northwestern Mutual Wealth Management Co. raised its stake in Axon Enterprise by 30.6% during the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 802 shares of the biotechnology company’s stock valued at $236,000 after acquiring an additional 188 shares during the last quarter. Truist Financial Corp raised its stake in shares of Axon Enterprise by 53.4% during the second quarter. Truist Financial Corp now owns 6,467 shares of the biotechnology company’s stock worth $1,903,000 after purchasing an additional 2,251 shares during the last quarter. Sanctuary Advisors LLC purchased a new position in Axon Enterprise in the 2nd quarter valued at $836,000. Czech National Bank increased its stake in Axon Enterprise by 8.2% in the 3rd quarter. Czech National Bank now owns 14,625 shares of the biotechnology company’s stock valued at $5,844,000 after buying an additional 1,107 shares during the period. Finally, GAMMA Investing LLC raised its position in Axon Enterprise by 53.9% during the 3rd quarter. GAMMA Investing LLC now owns 985 shares of the biotechnology company’s stock worth $394,000 after buying an additional 345 shares during the last quarter. 79.08% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at Axon Enterprise

In related news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total transaction of $271,831.50. Following the transaction, the director now directly owns 6,929 shares in the company, valued at approximately $4,185,601.03. This represents a 6.10 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, Director Julie A. Cullivan sold 1,261 shares of Axon Enterprise stock in a transaction dated Wednesday, December 4th. The shares were sold at an average price of $682.06, for a total value of $860,077.66. Following the completion of the sale, the director now owns 2,392 shares of the company’s stock, valued at $1,631,487.52. This trade represents a 34.52 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 50,545 shares of company stock valued at $30,721,337. Company insiders own 5.70% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts have recently weighed in on AXON shares. Robert W. Baird lifted their target price on shares of Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a report on Friday, December 6th. Northland Securities boosted their target price on Axon Enterprise from $365.00 to $550.00 and gave the stock an “outperform” rating in a research report on Monday, November 11th. Needham & Company LLC increased their target price on Axon Enterprise from $525.00 to $600.00 and gave the stock a “buy” rating in a research note on Friday, November 8th. TD Cowen initiated coverage on Axon Enterprise in a research report on Wednesday, January 8th. They issued a “buy” rating and a $700.00 price objective for the company. Finally, The Goldman Sachs Group upped their price target on shares of Axon Enterprise from $500.00 to $700.00 and gave the stock a “buy” rating in a research note on Monday, January 27th. One investment analyst has rated the stock with a hold rating and fourteen have issued a buy rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $542.15.

Axon Enterprise Price Performance

NASDAQ:AXON opened at $677.40 on Friday. The firm has a market cap of $51.65 billion, a price-to-earnings ratio of 175.04, a price-to-earnings-growth ratio of 6.54 and a beta of 1.05. Axon Enterprise, Inc. has a 12-month low of $255.68 and a 12-month high of $698.67. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. The company’s 50-day moving average is $622.79 and its two-hundred day moving average is $491.30.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.